• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于改善口服和局部给药的载阿仑膦酸盐修饰药物递送脂质颗粒

Alendronate-Loaded Modified Drug Delivery Lipid Particles Intended for Improved Oral and Topical Administration.

作者信息

Ochiuz Lacramioara, Grigoras Cristian, Popa Marcel, Stoleriu Iulian, Munteanu Corneliu, Timofte Daniel, Profire Lenuta, Grigoras Anca Giorgiana

机构信息

Department of Pharmaceutical Technology, Faculty of Pharmacy, Grigore T. Popa University of Medicine and Pharmacy of Iasi, Universitatii Street, 16, Iasi 700115, Romania.

Petru Poni Institute of Macromolecular Chemistry, Aleea, Grigore Ghica Voda, 41A, Iasi 700487, Romania.

出版信息

Molecules. 2016 Jun 29;21(7):858. doi: 10.3390/molecules21070858.

DOI:10.3390/molecules21070858
PMID:27367664
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6272979/
Abstract

The present paper focuses on solid lipid particles (SLPs), described in the literature as the most effective lipid drug delivery systems that have been introduced in the last decades, as they actually combine the advantages of polymeric particles, hydrophilic/lipophilic emulsions and liposomes. In the current study, we present our most recent advances in the preparation of alendronate (AL)-loaded SLPs prepared by hot homogenization and ultrasonication using various ratios of a self-emulsifying lipidic mixture of Compritol 888, Gelucire 44/14, and Cremophor A 25. The prepared AL-loaded SLPs were investigated for their physicochemical, morphological and structural characteristics by dynamic light scattering, differential scanning calorimetry, thermogravimetric and powder X-ray diffraction analysis, infrared spectroscopy, optical and scanning electron microscopy. Entrapment efficacy and actual drug content were assessed by a validated HPLC method. In vitro dissolution tests performed in simulated gastro-intestinal fluids and phosphate buffer solution pH 7.4 revealed a prolonged release of AL of 70 h. Additionally, release kinetics analysis showed that both in simulated gastrointestinal fluids and in phosphate buffer solution, AL is released from SLPs based on equal ratios of lipid excipients following zero-order kinetics, which characterizes prolonged-release drug systems.

摘要

本文聚焦于固体脂质颗粒(SLPs),文献中将其描述为过去几十年中引入的最有效的脂质药物递送系统,因为它们实际上结合了聚合物颗粒、亲水/亲脂性乳液和脂质体的优点。在当前研究中,我们展示了通过热均质化和超声处理,使用Compritol 888、Gelucire 44/14和Cremophor A 25的自乳化脂质混合物的各种比例制备载阿仑膦酸盐(AL)的SLPs的最新进展。通过动态光散射、差示扫描量热法、热重分析和粉末X射线衍射分析、红外光谱、光学和扫描电子显微镜对制备的载AL的SLPs的物理化学、形态和结构特征进行了研究。通过经过验证的高效液相色谱法评估包封率和实际药物含量。在模拟胃肠液和pH 7.4的磷酸盐缓冲溶液中进行的体外溶出试验显示,AL的释放延长至70小时。此外,释放动力学分析表明,在模拟胃肠液和磷酸盐缓冲溶液中,AL均基于脂质辅料的等比例从SLPs中以零级动力学释放,这是长效释放药物系统的特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f097/6272979/f389994d5d98/molecules-21-00858-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f097/6272979/7e6f29dc0df7/molecules-21-00858-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f097/6272979/db177216b75d/molecules-21-00858-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f097/6272979/9955f200ab48/molecules-21-00858-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f097/6272979/5799f2eae0bf/molecules-21-00858-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f097/6272979/d2ba195abff3/molecules-21-00858-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f097/6272979/723f43ceb0a5/molecules-21-00858-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f097/6272979/794fa2d4e320/molecules-21-00858-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f097/6272979/3b8718af40ee/molecules-21-00858-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f097/6272979/f389994d5d98/molecules-21-00858-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f097/6272979/7e6f29dc0df7/molecules-21-00858-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f097/6272979/db177216b75d/molecules-21-00858-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f097/6272979/9955f200ab48/molecules-21-00858-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f097/6272979/5799f2eae0bf/molecules-21-00858-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f097/6272979/d2ba195abff3/molecules-21-00858-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f097/6272979/723f43ceb0a5/molecules-21-00858-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f097/6272979/794fa2d4e320/molecules-21-00858-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f097/6272979/3b8718af40ee/molecules-21-00858-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f097/6272979/f389994d5d98/molecules-21-00858-g009.jpg

相似文献

1
Alendronate-Loaded Modified Drug Delivery Lipid Particles Intended for Improved Oral and Topical Administration.用于改善口服和局部给药的载阿仑膦酸盐修饰药物递送脂质颗粒
Molecules. 2016 Jun 29;21(7):858. doi: 10.3390/molecules21070858.
2
Preparation, optimization and characterization of bovine lactoferrin-loaded liposomes and solid lipid particles modified by hydrophilic polymers using factorial design.采用因子设计法制备、优化并表征经亲水性聚合物修饰的载有牛乳铁蛋白的脂质体和固体脂质颗粒。
Chem Biol Drug Des. 2014 May;83(5):560-75. doi: 10.1111/cbdd.12269. Epub 2014 Mar 14.
3
High payload nanostructured lipid carriers fabricated with alendronate/polyethyleneimine ion complexes.载药量高的纳米结构脂质载体的制备与阿仑膦酸钠/聚乙烯亚胺离子复合物。
Int J Pharm. 2018 Jan 15;535(1-2):148-156. doi: 10.1016/j.ijpharm.2017.10.064. Epub 2017 Nov 8.
4
Development of dry powder inhaler formulation loaded with alendronate solid lipid nanoparticles: solid-state characterization and aerosol dispersion performance.载阿仑膦酸钠固体脂质纳米粒的干粉吸入剂制剂的研制:固态表征和气溶胶分散性能
Drug Dev Ind Pharm. 2015;41(9):1431-7. doi: 10.3109/03639045.2014.956111. Epub 2015 Jul 21.
5
Spray-congealed solid lipid microparticles as a new tool for the controlled release of bisphosphonates from a calcium phosphate bone cement.喷雾冷冻固脂微球作为一种新工具控制双膦酸盐从磷酸钙骨水泥中的释放。
Eur J Pharm Biopharm. 2018 Jan;122:6-16. doi: 10.1016/j.ejpb.2017.10.002. Epub 2017 Oct 3.
6
Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system.通过黏附性脂质体给药系统提高阿仑膦酸钠的口服生物利用度。
Eur J Pharm Sci. 2012 Aug 15;46(5):500-7. doi: 10.1016/j.ejps.2012.04.002. Epub 2012 Apr 13.
7
In situ fabrication of alendronate-loaded calcium phosphate microspheres: controlled release for inhibition of osteoclastogenesis.原位制备载阿仑膦酸钠的磷酸钙微球:抑制破骨细胞生成的控制释放。
J Control Release. 2010 Oct 1;147(1):45-53. doi: 10.1016/j.jconrel.2010.06.016. Epub 2010 Jun 30.
8
Biomimetic mineralization of nanocrystalline hydroxyapatites on aminated modified polylactic acid microspheres to develop a novel drug delivery system for alendronate.纳米晶羟基磷灰石在氨基化改性聚乳酸微球上的仿生矿化,以开发一种新型的阿仑膦酸钠药物传递系统。
Mater Sci Eng C Mater Biol Appl. 2020 May;110:110655. doi: 10.1016/j.msec.2020.110655. Epub 2020 Jan 8.
9
Evaluating two nanocarrier systems for the transdermal delivery of sodium alendronate.评价两种用于经皮传递阿仑膦酸钠的纳米载体系统。
Int J Pharm. 2020 May 30;582:119312. doi: 10.1016/j.ijpharm.2020.119312. Epub 2020 Apr 8.
10
Modulation of Alendronate release from a calcium phosphate bone cement: An in vitro osteoblast-osteoclast co-culture study.从磷酸钙骨水泥中释放阿仑膦酸钠的调控:体外成骨细胞-破骨细胞共培养研究。
Int J Pharm. 2019 Jan 10;554:245-255. doi: 10.1016/j.ijpharm.2018.11.023. Epub 2018 Nov 10.

引用本文的文献

1
Alendronate as Bioactive Coating on Titanium Surfaces: An Investigation of CaP-Alendronate Interactions.阿仑膦酸盐作为钛表面的生物活性涂层:钙磷-阿仑膦酸盐相互作用的研究。
Materials (Basel). 2024 Jun 3;17(11):2703. doi: 10.3390/ma17112703.
2
Polydopamine-Modified Titanium Dioxide Nanotube Arrays Doped with Calcium as a Sustained Drug Delivery System.聚多巴胺修饰的掺钙二氧化钛纳米管阵列作为一种药物缓释系统
ACS Omega. 2024 Jan 19;9(4):4949-4956. doi: 10.1021/acsomega.3c08772. eCollection 2024 Jan 30.
3
Self-emulsifying micelles as a drug nanocarrier system for itraconazole oral bioavailability enhancement; and assessment.

本文引用的文献

1
Formulation, characterization and cytotoxicity studies of alendronate sodium-loaded solid lipid nanoparticles.阿仑膦酸钠负载固体脂质纳米粒的制剂、表征及细胞毒性研究
Colloids Surf B Biointerfaces. 2014 May 1;117:21-8. doi: 10.1016/j.colsurfb.2014.01.055. Epub 2014 Feb 9.
2
Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers - a systematic review of in vitro data.纳米毒理学在固体脂质纳米粒和纳米结构脂质载体中的应用——体外数据的系统评价。
Eur J Pharm Biopharm. 2014 May;87(1):1-18. doi: 10.1016/j.ejpb.2014.02.005. Epub 2014 Feb 12.
3
Drug carriers in osteoporosis: preparation, drug encapsulation and applications.
自乳化微乳作为一种提高伊曲康唑口服生物利用度的药物纳米载体系统及其评估。
Saudi Pharm J. 2023 Dec;31(12):101839. doi: 10.1016/j.jsps.2023.101839. Epub 2023 Oct 28.
4
Fabrication of Celecoxib PVP Microparticles Stabilized by Gelucire 48/16 via Electrospraying for Enhanced Anti-Inflammatory Action.通过电喷雾法制备由Gelucire 48/16稳定的塞来昔布聚维酮微粒以增强抗炎作用
Pharmaceuticals (Basel). 2023 Feb 8;16(2):258. doi: 10.3390/ph16020258.
5
Formulation and Evaluation of Niosomal Alendronate Sodium Encapsulated in Polymeric Microneedles: In Vitro Studies, Stability Study and Cytotoxicity Study.聚合物微针包封的阿仑膦酸钠脂质体的制剂与评价:体外研究、稳定性研究和细胞毒性研究
Nanomaterials (Basel). 2022 Oct 12;12(20):3570. doi: 10.3390/nano12203570.
6
Surface Functionalisation of Dental Implants with a Composite Coating of Alendronate and Hydrolysed Collagen: DFT and EIS Studies.阿仑膦酸盐与水解胶原蛋白复合涂层对牙种植体的表面功能化:密度泛函理论和电化学阻抗谱研究
Materials (Basel). 2022 Jul 23;15(15):5127. doi: 10.3390/ma15155127.
7
Tenofovir Hot-Melt Granulation using Gelucire to Develop Sustained-Release Vaginal Systems for Weekly Protection against Sexual Transmission of HIV.使用Gelucire进行替诺福韦热熔制粒以开发每周一次预防HIV性传播的缓释阴道给药系统。
Pharmaceutics. 2019 Mar 20;11(3):137. doi: 10.3390/pharmaceutics11030137.
8
Inhibition of bcl-2 and cox-2 Protein Expression after Local Application of a New Carmustine-Loaded Clinoptilolite-Based Delivery System in a Chemically Induced Skin Cancer Model in Mice.新型载卡莫司汀沸石给药系统局部给药抑制化学诱导的小鼠皮肤癌模型中 bcl-2 和 cox-2 蛋白表达。
Molecules. 2017 Nov 20;22(11):2014. doi: 10.3390/molecules22112014.
9
Application of Soluplus to Improve the Flowability and Dissolution of Baicalein Phospholipid Complex.应用Soluplus改善黄芩苷磷脂复合物的流动性和溶出度。
Molecules. 2017 May 11;22(5):776. doi: 10.3390/molecules22050776.
10
Artemisinin and Its Derivatives as a Repurposing Anticancer Agent: What Else Do We Need to Do?青蒿素及其衍生物作为一种重新利用的抗癌药物:我们还需要做些什么?
Molecules. 2016 Oct 7;21(10):1331. doi: 10.3390/molecules21101331.
骨质疏松症中的药物载体:制备、药物包封和应用。
Int J Pharm. 2013 Mar 10;445(1-2):181-95. doi: 10.1016/j.ijpharm.2013.01.031. Epub 2013 Jan 31.
4
Predictive modeling of insulin release profile from cross-linked chitosan microspheres.交联壳聚糖微球中胰岛素释放特性的预测模型。
Eur J Med Chem. 2013 Feb;60:249-53. doi: 10.1016/j.ejmech.2012.12.011. Epub 2012 Dec 19.
5
Formulation optimization and topical delivery of quercetin from solid lipid based nanosystems.从基于固体脂质的纳米系统中优化槲皮素的配方并实现其局部递送。
Int J Pharm. 2013 Jan 30;441(1-2):56-66. doi: 10.1016/j.ijpharm.2012.12.013. Epub 2012 Dec 20.
6
Biocompatibility of engineered nanoparticles for drug delivery.用于药物输送的工程纳米颗粒的生物相容性。
J Control Release. 2013 Mar 10;166(2):182-94. doi: 10.1016/j.jconrel.2012.12.013. Epub 2012 Dec 20.
7
Development of solid lipid nanoparticles (SLNs) of lopinavir using hot self nano-emulsification (SNE) technique.洛匹那韦固体脂质纳米粒(SLNs)的热自乳化(SNE)技术制备。
Eur J Pharm Sci. 2013 Jan 23;48(1-2):231-9. doi: 10.1016/j.ejps.2012.10.022. Epub 2012 Nov 12.
8
Polymeric nanocarriers for controlled and enhanced delivery of therapeutic agents to the CNS.用于将治疗剂可控且增强地递送至中枢神经系统的聚合物纳米载体。
Ther Deliv. 2012 Jul;3(7):875-87. doi: 10.4155/tde.12.55.
9
In vitro biocompatibility of solid lipid nanoparticles.固体脂质纳米粒的体外生物相容性。
Sci Total Environ. 2012 Aug 15;432:382-8. doi: 10.1016/j.scitotenv.2012.06.018. Epub 2012 Jul 1.
10
Improvement of drug safety by the use of lipid-based nanocarriers.通过使用基于脂质的纳米载体来改善药物安全性。
J Control Release. 2012 Oct 10;163(1):34-45. doi: 10.1016/j.jconrel.2012.06.002. Epub 2012 Jun 12.